Free Trial

Atea Pharmaceuticals (AVIR) News Today

Atea Pharmaceuticals logo
$3.74 +0.12 (+3.17%)
As of 11:02 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AVIR Latest News

AVIR Atea Pharmaceuticals, Inc. - Seeking Alpha
Atea Pharmaceuticals says strategic alternatives process ‘ongoing’
Morgan Stanley Remains a Hold on Atea Pharmaceuticals (AVIR)
Atea Pharmaceuticals, Inc. (AVIR): A Bull Case Theory
Atea Pharmaceuticals reports Q4 EPS (40c), consensus (29c)
Get Atea Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVIR and its competitors with MarketBeat's FREE daily newsletter.

AVIR Media Mentions By Week

AVIR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVIR
News Sentiment

1.89

0.90

Average
Medical
News Sentiment

AVIR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVIR Articles
This Week

1

2

AVIR Articles
Average Week

Get Atea Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVIR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:AVIR) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners